MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Prostate
OPKO HEALTH INC (NASDAQ: OPK)*
Organization & Developments: Opko
Parents
OPKO HEALTH INC (NASDAQ: OPK)*
Children
2016: Biotech Forum Daily Digest: OPKO Gets Early FDA Approval, Zika Virus Again In The News, Spotlight On XBiotech
2016: OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3
2017: VA_65--65IB OPKO Pharmaceuticals, LLC Effective Date: July 15, 2017 to July 14, 2022
2018: Opko Health: The Importance Of The 4kscore Test Study - OPKO Health, Inc. (NYSEMKT:OPK)
2019: Third medical testing company impacted by AMCA breach as Congress seeks answers
2020: Analyzing OPKO Health, Inc. Beyond The COVID Testing Bonanza
2020: OPKO Health: A $10 Stock On Sale Now For Only $4
2020: OPKO Health: Current Valuation Creates An Interesting Opportunity
2020: Pounding The Table For Undervalued OPKO Health
2023: OPKO Health's Future After Merck Deal: Bright Or Uncertain_ seekingalpha.com
An expanding biologic product portfolio
It has strategic license agreements with the University of Texas, Southwestern Medical Center, Academia Sinica, the University of Pennsylvania, the University of Florida Research Foundation, and Redox Pharmaceuticals.
OPKO's diagnostics segment, BioReference Laboratories ("BRL"), which has become the third-largest provider of laboratory testing services in the country
Solid late-stage pipeline so it has the multiple "shots on goal"
Specialty healthcare company, engages in the discovery, development, and commercialization of pharmaceutical products, medical devices, vaccines, diagnostic technologies, and imaging systems for treatment and management of ophthalmic diseases.
The company's business consists of the nation's third-largest clinical laboratory with a core genetic testing business
Jumps
*Key People: Opko
Finance & Acquisitions: Opko